Frederiksberg Hospital is a medium-sized government-owned general hospital located in Frederiksberg, Denmark. It has 380 beds and an emergency department. The hospital is a teaching hospital for medical students from Copenhagen University.

During the past decade, Urological department, Frederiksberg Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Urological department, Frederiksberg Hospital" are "Bladder Cancer" (2 trials). Many other conditions were trialed in "Urological department, Frederiksberg Hospital" in a lesser frequency.

Most popular intervention types in "Urological department, Frederiksberg Hospital" are "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bladder tumor resection using diathermia" (1 trials), "Diode laser (980 nm) tumor destruction" (1 trials) and "Laser treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Urological department, Frederiksberg Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Urological department, Frederiksberg Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Urological department, Frederiksberg Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Urological department, Frederiksberg Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".